Upadacitinib for treatment‐resistant Lichen amyloidosis-Reference-Cited by-同舟云学术

Upadacitinib for treatment‐resistant Lichen amyloidosis

Published:2022-11-26 Issue:5 Volume:37 Page:
ISSN:0926-9959
Container-title:Journal of the European Academy of Dermatology and Venereology
language:en
Short-container-title:Acad Dermatol Venereol

Author:

Solimani Farzan¹²^ORCID,Dilling Amrei¹,Ghoreschi Franziska C.¹,Nast Alexander¹^ORCID,Ghoreschi Kamran¹,Meier Katharina¹^ORCID

Affiliation:

1. Department of Dermatology, Venereology and Allergology Charité‐Universitätsmedizin Berlin Berlin Germany

2. Berlin Institute of Health at Charité – Universitätsmedizin Berlin BIH Biomedical Innovation Academy, BIH Charité Clinician Scientist Program Berlin Germany

Funder

Charité – Universitätsmedizin Berlin

Berlin Institute of Health

Publisher

Wiley

Subject

Infectious Diseases,Dermatology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/jdv.18756

Reference10 articles.

1. Primary Localized Cutaneous Amyloidosis: A Systematic Treatment Review

2. OSMRβ mutants enhance basal keratinocyte differentiation via inactivation of the STAT5/KLF7 axis in PLCA patients

3. New insight into mechanisms of pruritus from molecular studies on familial primary localized cutaneous amyloidosis

4. A sensory neuron–expressed IL-31 receptor mediates T helper cell–dependent itch: Involvement of TRPV1 and TRPA1

5. Refractory cutaneous lichen amyloidosis coexisting with atopic dermatitis responds to the Janus Kinase inhibitor baricitinib

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Lichen Amyloidosis in an Atopic Patient Treated with Dupilumab: A New Therapeutic Option;Diseases;2024-05-06

2. Primary localized cutaneous amyloidosis associated with atopic dermatitis treated successfully with nemolizumab;Journal of the European Academy of Dermatology and Venereology;2024-04-18